Print

Nabi Biopharmaceuticals (NABI) Announces Second Quarter 2012 Financial Results  
8/10/2012 10:03:45 AM

ROCKVILLE, Md., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three-month period ended June 30, 2012. The Company reported a net loss of $2.7 million, or $0.06 per share, compared to net loss of $4.6 million, or $0.11 per share, for the prior year period.
//-->